tiprankstipranks
Trending News
More News >
Cytek Biosciences (CTKB)
NASDAQ:CTKB
US Market
Advertisement

Cytek Biosciences (CTKB) Earnings Dates, Call Summary & Reports

Compare
62 Followers

Earnings Data

Report Date
Mar 04, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
<0.01
Last Year’s EPS
0.12
Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 05, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call reflects a mixture of positive and negative elements. While there are significant achievements in revenue growth in APAC, service, and reagent sectors, challenges remain in the EMEA region and the U.S. academic and government sectors. Increased operating expenses and a net loss also weigh negatively, balancing out the positive aspects.
Company Guidance
During the Cytek Biosciences Third Quarter 2025 Earnings Conference Call, the company provided guidance indicating a stable financial outlook. Total revenue for the third quarter reached $52.3 million, marking a 2% year-over-year increase, driven by strong growth in the Asia Pacific region and recurring revenue from service and reagents. Revenue from instruments to pharma and biotech customers grew by 12% worldwide, with the U.S. seeing a 10% increase. Despite the positive performance in the U.S. and APAC, EMEA experienced a double-digit revenue decline. The company reaffirmed its full-year 2025 revenue guidance of $196 million to $205 million, highlighting continued strong momentum in service and reagents and stabilization in U.S. instrument revenues. Cytek also emphasized its strong market position, with an installed base of 3,456 units and a notable contribution from the Aurora Evo instruments, underscoring its commitment to sustained growth and market leadership.
Revenue Growth in APAC and Recurring Revenue
Total revenue reached $52.3 million, representing a year-over-year increase of 2%. This growth was primarily driven by strong double-digit gains in the Asia Pacific region and continued momentum in recurring revenue businesses, specifically service and reagents.
Strong Performance in APAC
APAC, including China, increased 25% in Q3, driven by growth in instruments, service, and reagents.
Reagent Revenue Growth
Reagent revenue grew 21% globally year-over-year, supported by operational improvements, including faster delivery times and enhanced customer service.
Service Revenue Growth
Service revenue continued to grow strongly with 19% growth in Q3 versus the prior year quarter.
Aurora Evo Instrument Launch
The Aurora Evo Analyzer was introduced and had a strong reception, contributing to instrument revenue growth.
Expansion of Cytek Cloud User Base
As of September 30, 2025, Cytek Cloud had more than 22,600 users, representing growth of over 40% since the beginning of 2025.

Cytek Biosciences (CTKB) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CTKB Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 04, 2026
2025 (Q4)
<0.01 / -
0.121
Nov 05, 2025
2025 (Q3)
-0.03 / <0.01
0.063-93.65% (-0.06)
Aug 06, 2025
2025 (Q2)
-0.05 / -0.04
-0.026-53.85% (-0.01)
May 08, 2025
2025 (Q1)
-0.03 / -0.09
-0.007-1185.71% (-0.08)
Feb 27, 2025
2024 (Q4)
0.10 / 0.12
0.0934.44% (+0.03)
Nov 05, 2024
2024 (Q3)
0.01 / 0.06
-0.008887.50% (+0.07)
Aug 06, 2024
2024 (Q2)
>-0.01 / -0.03
0.014-285.71% (-0.04)
May 08, 2024
2024 (Q1)
-0.03 / >-0.01
0
Feb 28, 2024
2023 (Q4)
0.03 / 0.09
0.0650.00% (+0.03)
Nov 07, 2023
2023 (Q3)
0.02 / >-0.01
0.04-120.00% (-0.05)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

CTKB Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 05, 2025
$4.01
Aug 06, 2025
$3.89$4.11+5.66%
May 08, 2025
$3.79$2.92-22.96%
Feb 27, 2025
$4.81$4.49-6.65%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Cytek Biosciences (CTKB) report earnings?
Cytek Biosciences (CTKB) is schdueled to report earning on Mar 04, 2026, After Close (Confirmed).
    What is Cytek Biosciences (CTKB) earnings time?
    Cytek Biosciences (CTKB) earnings time is at Mar 04, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is CTKB EPS forecast?
          CTKB EPS forecast for the fiscal quarter 2025 (Q4) is <0.01.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis